Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples